Medtronic received FDA approval for its PulseSelect system to become the first pulsed-field ablation catheter approved in the US in December 2023. Boston Scientific gained US approval for its ...

While several effective treatment options for AFib exist, current evidence strongly suggests that pulsed field ablation (PFA) ...

Medtronic was the latest company to outline a bright future for pulsed field ablation (PFA). Physicians have embraced PFA over radiofrequency and cryoablation to treat atrial fibrillation since ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Revenue for Medtronic’s Cardiac Ablation Solutions business increased by digits in the low-20s, spurred by the growth of the company’s two pulsed field ablation (PFA) systems PulseSelect and ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

With the introduction of pulsed-field ablation, patients can have a non-thermal form of ablation. This technology delivers pulsed electrical fields through an ablation catheter to selectively ...

For example, the versatile Affera in pulsed field ablation drove Medtronic's PFA business up 22% in the quarter. We expect this double-digit growth to continue into fiscal 2026. We think Medtronic ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.

LONDON, Feb. 4, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: ...